Abstract
The tumor suppressor BRCA2 plays a key role in genome integrity by promoting replication-fork stability and homologous recombination (HR) DNA repair. Here we report that human cancer cells lacking BRCA2 rely on the Fanconi anemia protein FANCD2 to limit replication-fork progression and genomic instability. Our results identify a new role of FANCD2 in limiting constitutive replication stress in BRCA2-deficient cells, thereby affecting cell survival and treatment responses.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Zimmer, J. et al. Mol. Cell 61, 449–460 (2016).
Badie, S. et al. Nat. Struct. Mol. Biol. 17, 1461–1469 (2010).
Schlacher, K. et al. Cell 145, 529–542 (2011).
Lomonosov, M., Anand, S., Sangrithi, M., Davies, R. & Venkitaraman, A.R. Genes Dev. 17, 3017–3022 (2003).
Schlacher, K., Wu, H. & Jasin, M. Cancer Cell 22, 106–116 (2012).
Lachaud, C. et al. Science 351, 846–849 (2016).
Lossaint, G. et al. Mol. Cell 51, 678–690 (2013).
Michl, J., Zimmer, J. & Tarsounas, M. EMBO J. 35, 909–923 (2016).
Zeman, M.K. & Cimprich, K.A. Nat. Cell Biol. 16, 2–9 (2014).
Chaudhury, I., Sareen, A., Raghunandan, M. & Sobeck, A. Nucleic Acids Res. 41, 6444–6459 (2013).
Carlos, A.R. et al. Nat. Commun. 4, 2697 (2013).
Chen, Y.H. et al. Mol. Cell 58, 323–338 (2015).
Jackson, S.P. & Bartek, J. Nature 461, 1071–1078 (2009).
Nijman, S.M. FEBS Lett. 585, 1–6 (2011).
Kim, Y. et al. Blood 121, 54–63 (2013).
Forbes, S.A. et al. Nucleic Acids Res. 43, D805–D811 (2015).
Irizarry, R.A. et al. Biostatistics 4, 249–264 (2003).
Dai, M. et al. Nucleic Acids Res. 33, e175 (2005).
Ciriello, G. et al. Cell 163, 506–519 (2015).
Acknowledgements
We thank S. Bertrand for assistance with the senescence assays. We are grateful to G. Brown and M. Woodcock for assistance with microscopy and FACS analyses, respectively. J.Z. is supported by a Cancer Research UK PhD Studentship. The laboratory of M.T. is funded by Cancer Research UK A17201, the Medical Research Council, the University of Oxford and the EMBO Young Investigator Programme.
Author information
Authors and Affiliations
Contributions
M.T., J.M. and J.Z. designed the study and the experiments. J.Z. and M.T. wrote the paper. J.M. and J.Z. performed the experiments. U.M. and F.M.B. analyzed FANCD2 expression levels in cell lines and tumors, respectively.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Integrated supplementary information
Supplementary Figure 1 Depletion of FANCD2 and BRCA2 leads to increased origin firing in HEK-293T cells.
(a) HEK-293T cells were transfected with siRNAs against BRCA2 and/or FANCD2 and cell extracts were processed for immunoblotting 72 h after transfection. SMC1 was used as a loading control. (b) Quantification of newly fired origins of fiber experiments in Figure 1f. n = 3 (independent experiments). error bars, SEM; *, p < 0.05 (unpaired, two-tailed t test).
Supplementary Figure 2 Loss of FANCD2 increases senescence in BRCA2-deficient MRC-5 cells.
(a) MRC-5 cells were transfected with siRNAs against BRCA2 and/or FANCD2 and cell extracts were processed for immunoblotting 48 h after transfection. SMC1 was used as a loading control. (b) Loss of FANCD2 induces senescence in BRCA2-depleted MRC-5 cells as assessed by β-galactosidase staining. n = 3 (independent experiments); error bars, SEM; ***, p < 0.001; ****, p < 0.0001 (unpaired, two-tailed t test). (c) Representative images of quantification shown in (b).
Supplementary Figure 3 FANCD2 and BRCA2 are synthetic lethal.
(a) H1299 cells harbouring Dox-inducible shRNA against BRCA2 were transfected with two different siRNAs against FANCD2 and processed for immunoblotting 72 h after transfection. SMC1 was used as a loading control. (b) Clonogenic survival assays in H1299 cells transfected with FANCD2 esiRNA. n = 3 (independent experiments); error bars, SEM; ***, p < 0.001 (unpaired, two-tailed t test). (c) BRCA2-proficient (+BRCA2) or -deficient (–BRCA2) DLD1 cells were transfected with esiRNA against FANCD2 and processed for immunoblotting 72 h after transfection. SMC1 was used as a loading control. (d) MDA-MB-231 cells harbouring Dox-inducible shRNA against BRCA2 were transfected with siRNA against FANCD2 and processed for immunoblotting 72 h after transfection. SMC1 was used as a loading control. (e) FANCD2-proficient (+FANCD2) or -deficient (–FANCD2) DLD1 cells were transfected with siRNA against BRCA2 and processed for immunoblotting 72 h after transfection. SMC1 was used as a loading control. (f) Clonogenic survival assays in MDA-MB-231 cells transfected with FANCA siRNA. n = 3 (independent experiments); error bars, SEM; *, p < 0.05 (unpaired, two-tailed t test).
Supplementary Figure 4 Schematic illustrating BRCA2 mutations found in breast tumors.
Breast tumors were analyzed in Figure 2f. H, helical domain. OB, oligonucleotide-binding domain. T, tower domain. NLS, nuclear localization sequence.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–4 and Supplementary Tables 1–7 (PDF 766 kb)
Supplementary Data Set 1
Uncropped blots shown in Figure 1a. (PDF 125 kb)
Rights and permissions
About this article
Cite this article
Michl, J., Zimmer, J., Buffa, F. et al. FANCD2 limits replication stress and genome instability in cells lacking BRCA2. Nat Struct Mol Biol 23, 755–757 (2016). https://doi.org/10.1038/nsmb.3252
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsmb.3252
This article is cited by
-
EYA4 promotes breast cancer progression and metastasis through its role in replication stress avoidance
Molecular Cancer (2023)
-
Hypomorphic Brca2 and Rad51c double mutant mice display Fanconi anemia, cancer and polygenic replication stress
Nature Communications (2023)
-
Stalled replication fork protection limits cGAS–STING and P-body-dependent innate immune signalling
Nature Cell Biology (2022)
-
Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma
Oncogenesis (2021)
-
Methodology for the identification of small molecule inhibitors of the Fanconi Anaemia ubiquitin E3 ligase complex
Scientific Reports (2020)